V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20025563 | 20010876 | null | 58.85 | Neo-adjuvant (N) | 2015-02-25 | 2015-03-26 | FEC 100 + DOCETAXEL | N | N | 20090233 | FEC + DOCETAXEL |
| 20025564 | 20010876 | 1.66 | 73.5 | Adjuvant (A) | 2013-04-15 | 2013-04-22 | FEC + DOCETAXEL | 02 | N | 20090233 | FEC + DOCETAXEL |
| 20025565 | 20010876 | null | 105 | Adjuvant (A) | 2015-09-16 | 2015-10-09 | FEC + DOCETAXEL | N | N | 20090233 | FEC + DOCETAXEL |
| 20025566 | 20010877 | null | null | null | 2013-09-24 | 2013-10-10 | FEC + DOCETAXEL | null | N | 20090245 | FEC + DOCETAXEL |
| 20025567 | 20010878 | 1.64 | 67 | Neo-adjuvant (N) | 2017-07-27 | 2017-08-10 | FEC + DOCETAXEL | null | null | 20090247 | FEC + DOCETAXEL |
| 20025568 | 20010878 | 1.71 | 100 | Neo-adjuvant (N) | 2013-12-21 | 2013-12-22 | FEC + DOCETAXEL | 02 | N | 20090247 | FEC + DOCETAXEL |
| 20025569 | 20010878 | 1.59 | 73.5 | Adjuvant (A) | 2017-06-03 | 2017-06-12 | FEC + DOCETAXEL | N | N | 20090247 | FEC + DOCETAXEL |
| 20025570 | 20010878 | null | 77.55 | Adjuvant (A) | 2015-12-31 | 2016-01-06 | FEC 100 + DOCETAXEL | N | null | 20090247 | FEC + DOCETAXEL |
| 20025571 | 20010878 | 1.67 | 57.8 | Adjuvant (A) | 2014-02-10 | 2014-02-10 | FEC 100 + DOCETAXEL | 02 | N | 20090247 | FEC + DOCETAXEL |
| 20025572 | 20010879 | 1.72 | 54.7 | Adjuvant (A) | 2016-12-14 | 2016-12-25 | FEC + DOCETAXEL | 02 | N | 20090262 | FEC + DOCETAXEL |
| 20025573 | 20010879 | 1.63 | 109.4 | Adjuvant (A) | 2016-10-02 | 2016-11-03 | FEC + DOCETAXEL | N | N | 20090262 | FEC + DOCETAXEL |
| 20025574 | 20010879 | 1.64 | null | Neo-adjuvant (N) | 2014-01-14 | 2014-02-04 | FEC 100 + DOCETAXEL | N | N | 20090262 | FEC + DOCETAXEL |
| 20025575 | 20127826 | 1.64 | 111.9 | null | 2017-08-22 | 2017-09-07 | FEC + DOCETAXEL | Y | N | 20090283 | FEC + DOCETAXEL |
| 20025576 | 20127826 | 1.71 | 97 | Neo-adjuvant (N) | 2013-08-12 | 2013-08-19 | FEC + DOCETAXEL | 2 | N | 20090283 | FEC + DOCETAXEL |
| 20025577 | 20010880 | 1.54 | 81 | Adjuvant (A) | 2017-09-20 | 2017-09-27 | FEC + DOCETAXEL | 02 | N | 20090289 | FEC + DOCETAXEL |
| 20025578 | 20010880 | null | 86.2 | Neo-adjuvant (N) | null | 2016-03-14 | FEC 100 + DOCETAXEL | null | null | 20090289 | FEC + DOCETAXEL |
| 20025579 | 20010880 | 1.55 | 59.05 | Adjuvant (A) | 2017-09-07 | 2017-09-27 | FEC + DOCETAXEL | 2 | N | 20090289 | FEC + DOCETAXEL |
| 20025583 | 20010882 | 1.71 | 80 | Adjuvant (A) | 2015-03-07 | 2015-03-07 | FEC + DOCETAXEL | 02 | Y | 20090309 | FEC + DOCETAXEL |
| 20025584 | 20010883 | null | null | Adjuvant (A) | 2013-12-21 | 2014-01-10 | FEC + DOCETAXEL | N | N | 20090315 | FEC + DOCETAXEL |
| 20025585 | 20010883 | 1.54 | 64.9 | Neo-adjuvant (N) | 2013-02-12 | 2013-03-04 | FEC + DOCETAXEL | N | N | 20090315 | FEC + DOCETAXEL |
| 20025586 | 20010884 | 1.61 | 72.3 | Adjuvant (A) | null | 2013-04-29 | FEC + DOCETAXEL | N | N | 20090322 | FEC + DOCETAXEL |
| 20025587 | 20010885 | 1.61 | 65.8 | Adjuvant (A) | 2016-07-27 | 2016-08-18 | FEC + DOCETAXEL | N | N | 20090323 | FEC + DOCETAXEL |
| 20025588 | 20010885 | null | 66 | null | 2014-12-29 | 2014-12-29 | FEC + DOCETAXEL | N | N | 20090323 | FEC + DOCETAXEL |
| 20025589 | 20010886 | 1.61 | 59.1 | Adjuvant (A) | 2014-10-18 | 2014-11-01 | FEC + DOCETAXEL | N | N | 20090332 | FEC + DOCETAXEL |
| 20025590 | 20010887 | 1.62 | 76 | Adjuvant (A) | null | 2017-03-05 | FEC + DOCETAXEL | N | N | 20090335 | FEC + DOCETAXEL |
| 20025591 | 20010887 | 1.5 | 70 | Adjuvant (A) | 2014-02-22 | 2014-03-21 | FEC 100 + DOCETAXEL | N | N | 20090335 | FEC + DOCETAXEL |
| 20025592 | 20010887 | 0 | 80 | Adjuvant (A) | 2014-01-29 | 2014-01-29 | FEC + DOCETAXEL | N | N | 20090335 | FEC + DOCETAXEL |
| 20025593 | 20010887 | 1.58 | 66.7 | Disease modification (D) | 2016-04-23 | 2016-04-23 | FEC + DOCETAXEL | 02 | Y | 20090335 | FEC + DOCETAXEL |
| 20025594 | 20010888 | 1.68 | null | Adjuvant (A) | 2016-07-09 | 2016-07-09 | FEC 100 + DOCETAXEL | N | N | 20090350 | FEC + DOCETAXEL |
| 20025595 | 20010888 | 1.5 | 59.7 | Not known (9) | 2014-05-16 | 2014-05-25 | FEC + DOCETAXEL | 02 | N | 20090350 | FEC + DOCETAXEL |
| 20025596 | 20010888 | 1.76 | null | Adjuvant (A) | 2016-04-17 | 2016-04-19 | FEC + DOCETAXEL | N | N | 20090350 | FEC + DOCETAXEL |
| 20025597 | 20010888 | 1.58 | null | Adjuvant (A) | 2017-07-31 | 2017-08-07 | FEC + DOCETAXEL | null | N | 20090350 | FEC + DOCETAXEL |
| 20025598 | 20010889 | 1.58 | 53.2 | Adjuvant (A) | null | 2013-04-25 | FEC + DOCETAXEL | null | null | 20090369 | FEC + DOCETAXEL |
| 20025599 | 20010889 | 1.66 | 76 | Adjuvant (A) | 2017-12-02 | 2017-12-02 | FEC + DOCETAXEL | 2 | N | 20090369 | FEC + DOCETAXEL |
| 20025600 | 20010889 | null | null | Adjuvant (A) | 2013-08-19 | 2013-08-27 | FEC 100 + DOCETAXEL | N | N | 20090369 | FEC + DOCETAXEL |
| 20025601 | 20010890 | 1.53 | 57 | Palliative (P) | 2013-08-23 | 2013-09-21 | FEC + DOCETAXEL | N | null | 20090380 | FEC + DOCETAXEL |
| 20025602 | 20010891 | 1.65 | 77.8 | Adjuvant (A) | 2016-12-14 | 2016-12-31 | FEC + DOCETAXEL | 02 | N | 20090381 | FEC + DOCETAXEL |
| 20025603 | 20010891 | 1.61 | 112 | Adjuvant (A) | 2013-11-26 | 2013-12-14 | FEC 100 + DOCETAXEL | N | N | 20090381 | FEC + DOCETAXEL |
| 20025604 | 20010892 | 1.64 | null | Adjuvant (A) | 2017-02-20 | 2017-03-10 | FEC + DOCETAXEL | N | N | 20090389 | FEC + DOCETAXEL |
| 20025605 | 20010892 | 1.67 | 58 | Adjuvant (A) | 2016-10-19 | 2016-10-19 | FEC 100 + DOCETAXEL | 02 | N | 20090389 | FEC + DOCETAXEL |
| 20025606 | 20010892 | 1.63 | 0 | Curative (C) | 2015-08-22 | 2015-09-01 | FEC + DOCETAXEL | 02 | N | 20090389 | FEC + DOCETAXEL |
| 20025607 | 20010893 | null | null | Adjuvant (A) | 2015-11-28 | 2015-12-11 | FEC 60 OR 75 + DOCETAXEL | N | N | 20090396 | FEC + DOCETAXEL |
| 20025608 | 20071365 | 1.66 | 61.8 | Adjuvant (A) | 2014-12-09 | 2014-12-09 | FEC + DOCETAXEL | 2 | N | 20090397 | FEC + DOCETAXEL |
| 20025609 | 20010894 | 1.69 | 87.4 | Not known (9) | 2017-01-11 | 2017-02-09 | FEC + DOCETAXEL | N | N | 20090398 | FEC + DOCETAXEL |
| 20025610 | 20010895 | 1.55 | 91 | Neo-adjuvant (N) | 2016-08-02 | 2016-08-03 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20090401 | FEC + DOCETAXEL |
| 20025611 | 20010895 | 1.68 | 61 | Adjuvant (A) | 2016-08-31 | 2016-08-31 | FEC + DOCETAXEL | 02 | N | 20090401 | FEC + DOCETAXEL |
| 20025612 | 20010896 | 1.65 | 77 | Neo-adjuvant (N) | 2014-05-26 | 2014-06-16 | FEC + DOCETAXEL | N | N | 20090410 | FEC + DOCETAXEL |
| 20025613 | 20010896 | 1.7 | null | null | 2013-10-19 | 2013-11-01 | FEC 100 + DOCETAXEL | N | N | 20090410 | FEC + DOCETAXEL |
| 20025614 | 20010897 | null | 87 | null | 2017-11-21 | 2017-12-01 | FEC + DOCETAXEL | N | null | 20090418 | FEC + DOCETAXEL |
| 20025615 | 20010898 | 1.64 | 110.4 | Disease modification (D) | 2016-07-06 | 2016-07-13 | FEC + DOCETAXEL | 02 | N | 20090420 | FEC + DOCETAXEL |